Key requirements concentration monitoring of monoclonal #Antibodies

Bing Kuang - PfizerAntibodies: Do you want to understand how to select an effective dosing regimen and understand the pharmacokinetics (PK) of your therapeutic mAb?

The key is to obtain accurate measurements of free and total drug concentration in both PK and pharmacodynamic (PD) analytical assays. But how?

Dr Bing Kuang, Senior Principal Scientist at Pfizer Inc., presented work into developing these analytical assays at the 7th annual European antibody congress 2011, and you can watch it in full below to hear his practical guidance for developing analytical assay formats for therapeutic mAb quantification.


Do you want to find out more ?

How to categorise #Antibodies

How Novartis are predicting #Antibody stability

Roche Glycart outline #Antibody mechanism of action: GA101

Leave a Reply

Your email address will not be published. Required fields are marked *